|6 Months Ended|
Jun. 30, 2022
6) Stockholders’ Deficit
We are authorized to issueshares of preferred stock with a par value of $ . Of the shares of preferred stock:
As of June 30, 2022, there were no shares of Junior A, and Series A, B, C and E issued and outstanding. See our Annual Report on Form 10-K for the year ended December 31, 2021 for the pertinent disclosures of preferred stock.
Stock Options and Warrants
At the Company’s December 30, 2021 Special Meeting, the shareholder’s approved the 2021 Equity Incentive Plan (the “2021 Plan”) pursuant to whichshares of our common stock were reserved for issuance upon exercise of stock options or other equity awards. Consistent with the Company’s existing 2013 Equity Incentive plan (the “2013 plan”), under the 2021 plan, we may award stock options, shares of common stock, and other equity interests in the Company to employees, officers, directors, consultants, and advisors, and to any other persons the Board of Directors deems appropriate. As of June 30, 2022, options to acquire shares were outstanding under these Plans.
As of June 30, 2022, total unrecognized compensation cost related to the unvested stock-based awards was $, which is expected to be recognized over weighted average period of years. The aggregate intrinsic value associated with the options outstanding and exercisable, and the aggregate intrinsic value associated with the warrants outstanding and exercisable as of June 30, 2022, based on the June 30, 2022 closing stock price of $ , was $ .
The following table summarizes information concerning options and warrants outstanding and exercisable:
Schedule of Concerning Options and Warrants Outstanding and Exercisable
As of June 30, 2022, theoptions outstanding have a $ weighted average exercise price and years weighted average remaining term. Of these options, are currently exercisable.
Common Stock and Warrant Issuances
Schedule of Loans Obligated to Issue Shares
For the three-month and six-month period ended June 30, 2022, the Company is obligated to issue 388,515 and $1,553,765, respectively in interest expense for these obligations to issue common stock.and shares of common stock, respectively, for the loans listed in the above table, but has not issued the shares. The Company and the lenders are negotiating in good faith to resolve these loans. During the three-month and six-month period ended June 30, 2022, the Company accrued $
During the six months ended June 30, 2022, the Company issued a total of 350,500 were issued for the conversion of debt and interest for common stock, of the shares with a fair value of $1,561,973 were issued for interest paid-in-kind, of the shares with a fair value of $145,500 were issued for services rendered, shares with a fair value of $215,277 for dividends paid-in-kind, shares with a fair value of $178,328 for new convertible debt issuances, shares with a fair value of $17,433 from a stock option exercise, shares with a fair value of $664,203 for debt extension and shareholders converted shares of Series AA Convertible Preferred Stock into shares of common stock.shares of restricted common stock to accredited investors and consultants. of the shares with a fair value of $
During the six months ended June 30, 2022, we issued 100,000 warrants (-year term at a $ exercise price) to acquire common stock at a fair value of $87,436 to a lender in conjunction with signing of new convertible loans. We also issued 30,000 warrants (-year term at a $ exercise price) with a fair value of $39,761 for services rendered and 100,000 warrants (-year term at a $ exercise price) with a fair value of $132,537 for debt extension.
During the six months ended June 30, 2021, we issued 3.5 million to lenders for interest paid-in-kind, shares with a fair value of $238,512 for services rendered, shares with a fair value of $349,250 for conversions of debt principal and interest, shares for stock option exercises (at an exercise price of $ per share), shares with a fair value of $114,298 for dividends paid-in-kind and shares with a fair value of $112,877 for Common Stock issued with debt. During this period, we also issued 1,374,600 warrants ( to -year term at a $3.50 to $5.00 exercise price) to acquire common stock at a fair value of $1.7 million to lenders in conjunction with signing of new convertible loans and interest paid-in-kind.shares of common stock with a fair value of approximately $
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef